Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.
about
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@ast
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@en
type
label
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@ast
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@en
prefLabel
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@ast
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@en
P2093
P2860
P356
P1476
Clinical Utility of Metrics Ba ...... s by Using Resampling Methods.
@en
P2093
Daniel J Sargent
Jan Bogaerts
Jeffrey P Meyers
Ming-Wen An
Sumithra J Mandrekar
P2860
P304
P356
10.1200/JCO.2015.60.8778
P407
P577
2015-10-26T00:00:00Z